menu
    • menu

    Company profile for BEIJING SL PHARMACEUTICAL

    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Leading pharmaceutical company, finished products: rh GCSF, rhIL-11, Asparaginase, Temozolomide, Paclitaxel, Gemcitabine, Granisetron, Tropisetron, Vinorelbine, Nimustine, Thymopentin-5, Arsenic trioxide, Octreotide, Somatostatin, Ciclosporin, Mycophenolate Mofetil, Lenalidomide, Dasatinib. API/Bulk/Ready to fill solution: rh PEG G-CSF, PEG L-Asparaginase, rh IFN?2a, rh IFN?2b, rh PEG IFN?2a, rh PEG IFN?2b, rh TNFaRII (Enterc...
    Leading pharmaceutical company, finished products: rh GCSF, rhIL-11, Asparaginase, Temozolomide, Paclitaxel, Gemcitabine, Granisetron, Tropisetron, Vinorelbine, Nimustine, Thymopentin-5, Arsenic trioxide, Octreotide, Somatostatin, Ciclosporin, Mycophenolate Mofetil, Lenalidomide, Dasatinib. API/Bulk/Ready to fill solution: rh PEG G-CSF, PEG L-Asparaginase, rh IFN?2a, rh IFN?2b, rh PEG IFN?2a, rh PEG IFN?2b, rh TNFaRII (Entercept), Bevacizumab, Trastuzumab, Infliximab, rh Somatropin, rh PTH 1-84, Ademetionine 1,4-butanedisulfonate.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    BEIJING SL PHARMACEUTICALChina Flag
    Country
    Country
    China
    Address
    Address
    Floor 4 Building 1, Bitong Garden, No. 69 Fushi Road Haidian District, Beijing...
    Telephone
    Telephone
    86 108 862 7630
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.slpharm.com.cn/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    FDF Dossiers

    read-more
    read-more

    01

    Brand Name : FEBUXOSTAT

    China
    VMX
    Not Confirmed
    arrow

    Brand Name : FEBUXOSTAT

    China
    arrow
    VMX
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info :

    Registration Country : USA

    FEBUXOSTAT

    BEIJING SL PHARMACEUTICAL

    Dosage Form : TABLET;ORAL

    Brand Name : FEBUXOSTAT

    Dosage Strength : 40MG

    Packaging :

    Approval Date :

    Application Number : 211339

    Regulatory Info :

    Registration Country : USA

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Brand Name : FEBUXOSTAT

    China
    VMX
    Not Confirmed
    arrow

    Brand Name : FEBUXOSTAT

    China
    arrow
    VMX
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info :

    Registration Country : USA

    FEBUXOSTAT

    BEIJING SL PHARMACEUTICAL

    Dosage Form : TABLET;ORAL

    Brand Name : FEBUXOSTAT

    Dosage Strength : 80MG

    Packaging :

    Approval Date :

    Application Number : 211339

    Regulatory Info :

    Registration Country : USA

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    FDA Orange Book

    read-more
    read-more

    01

    Brand Name : FEBUXOSTAT

    China
    VMX
    Not Confirmed
    arrow

    Brand Name : FEBUXOSTAT

    China
    VMX
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    RLD :

    TE Code :

    FEBUXOSTAT

    BEIJING SL PHARMACEUTICAL

    Dosage Form : TABLET; ORAL

    Proprietary Name : FEBUXOSTAT

    Dosage Strength : 40MG

    Approval Date :

    Application Number : 211339

    RX/OTC/DISCN :

    RLD :

    TE Code :

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Brand Name : FEBUXOSTAT

    China
    VMX
    Not Confirmed
    arrow

    Brand Name : FEBUXOSTAT

    China
    VMX
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    RLD :

    TE Code :

    FEBUXOSTAT

    BEIJING SL PHARMACEUTICAL

    Dosage Form : TABLET; ORAL

    Proprietary Name : FEBUXOSTAT

    Dosage Strength : 80MG

    Approval Date :

    Application Number : 211339

    RX/OTC/DISCN :

    RLD :

    TE Code :

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search